Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
Saved in:
| Title: | Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy. |
|---|---|
| Authors: | Burchard PR; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Ruffolo LI; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Ullman NA; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Dale BS; Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA., Dave YA; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Hilty BK; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Ye J; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Georger M; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Jewell R; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Miller C; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., De Las Casas L; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Jarolimek W; Drug Discovery, Syntara Ltd., Sydney, New South Wales, Australia., Perryman L; Drug Discovery, Syntara Ltd., Sydney, New South Wales, Australia., Byrne MM; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Loria A; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Marin C; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Chávez Villa M; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Yeh JJ; Departments of Surgery and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina System, Chapel Hill, North Carolina, USA., Belt BA; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Linehan DC; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Department of Surgery, Division of Surgical Oncology, University of Rochester Medical Center, Rochester, New York, USA., Hernandez-Alejandro R; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Division of Solid Organ Transplant Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA. |
| Source: | Hepatology communications [Hepatol Commun] 2024 Aug 05; Vol. 8 (8). Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
